LinKinVax

LinKinVax is a clinical-stage biotechnology company. LinKinVax is developing an innovative protein-based vaccine platform that can accelerate vaccine supply by leveraging research conducted by the Vaccine Research Institute (VRI). This DC Targeting-based protein vaccine platform can adapt to changes and mutations of target pathogens.